Nissay Asset Management Corp Jazz Pharmaceuticals PLC Transaction History

Nissay Asset Management Corp

$15.5 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$115.19 - $132.77 $11,634 - $13,409	101 Added 1.44%	7,094 $854,000
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $13,368 - $15,912	-117 Reduced 1.65%	6,993 $860,000
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $35,136 - $41,849	288 Added 4.22%	7,110 $920,000
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $8,575 - $10,301	-70 Reduced 1.02%	6,822 $845,000
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $34,030 - $40,759	-254 Reduced 3.55%	6,892 $1.01 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $34,635 - $42,679	-267 Reduced 3.6%	7,146 $1.14 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $43,420 - $55,284	343 Added 4.85%	7,413 $988,000
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $32,424 - $38,623	-229 Reduced 3.14%	7,070 $1.1 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $22,038 - $27,318	170 Added 2.38%	7,299 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $64,729 - $78,661	540 Added 8.2%	7,129 $908,000
Q3 2021 Nov 10, 2021	BUY	$128.64 - $184.79 $31,516 - $45,273	245 Added 3.86%	6,589 $858,000
Q2 2021 Aug 13, 2021	BUY	$160.2 - $186.42 $24,670 - $28,708	154 Added 2.49%	6,344 $1.13 Million
Q1 2021 May 11, 2021	SELL	$150.19 - $173.5 $12,615 - $14,574	-84 Reduced 1.34%	6,190 $1.02 Million
Q4 2020 Feb 08, 2021	SELL	$140.71 - $165.05 $22,935 - $26,903	-163 Reduced 2.53%	6,274 $1.04 Million
Q3 2020 Oct 20, 2020	BUY	$105.46 - $144.13 $11,706 - $15,998	111 Added 1.75%	6,437 $918,000
Q2 2020 Jul 27, 2020	BUY	$95.68 - $121.88 $56,642 - $72,152	592 Added 10.32%	6,326 $698,000
Q1 2020 May 05, 2020	BUY	$87.74 - $152.74 $10,616 - $18,481	121 Added 2.16%	5,734 $572,000
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $10,000 - $13,067	85 Added 1.54%	5,613 $838,000
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $22,407 - $25,639	179 Added 3.35%	5,528 $708,000
Q2 2019 Aug 07, 2019	SELL	$125.55 - $144.48 $23,226 - $26,728	-185 Reduced 3.34%	5,349 $763,000
Q1 2019 May 03, 2019	BUY	$121.81 - $142.95 $23,874 - $28,018	196 Added 3.67%	5,534 $791,000
Q4 2018 Feb 06, 2019	BUY	$115.94 - $166.74 $31,071 - $44,686	268 Added 5.29%	5,338 $662,000
Q3 2018 Oct 30, 2018	BUY	$161.01 - $180.57 $23,990 - $26,904	149 Added 3.03%	5,070 $852,000
Q2 2018 Aug 08, 2018	BUY	$146.33 - $183.18 $8,926 - $11,173	61 Added 1.26%	4,921 $848,000
Q1 2018 May 14, 2018	BUY	$135.59 - $157.16 $13,694 - $15,873	101 Added 2.12%	4,860 $734,000
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $623,714 - $715,706	4,759	4,759 $641,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account